MDMG OPENS MISCARRIAGE TREATMENT CENTRE AT PMC

MDMG OPENS MISCARRIAGE TREATMENT CENTRE AT PMC

8 June 2017, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, today announces the opening of the Miscarriage Treatment Centre at Perinatal Medical Centre (PMC) in Moscow.

The new centre is focused on pregnancy planning and screening for patients at high-risk of miscarriage, foetal genetic abnormalities, and preeclampsia. It will also offer prognosis and treatment for complications during pregnancy, delivery, and care for new-borns from 23 weeks of gestational age.

The centre comprises 10 beds, outpatient department, operating theatre, intensive care and therapy ward with extracorporeal methods of treatment. Annual capacity of Miscarriage Treatment Centre will be 36,500 patient-days.

The new department at PMC includes a prenatal care unit, intensive care unit for children, neonatal pathology unit, endoscopic surgery unit, clinical and molecular genetic laboratory, ultrasound unit, extracorporeal haemocorrection unit, CT and MRI facilities, as well as therapy and rheumatology units.

The Company's total investment in opening the new centre amounted to ca. RUB15 mln.

Mark Kurtser, CEO at MDMG, said:

"We are committed to providing high-quality medical services in every situation, including the most challenging ones, as this is well-recognised on the market. Today, we once again confirm this by opening the new Miscarriage Treatment Centre at Russia's first private maternity hospital - PMC, which has delivered around 30,000 babies to date.

"This is a specialised centre focused on providing care during complicated pregnancies and for premature children that is unparalleled in Russia due to its technical capabilities and the outstanding experience of our highly professional team.

"Today we have further demonstrated that MDMG does not only scale up existing medical technology, but also constantly developing new and unique methods".

For further information please contact:

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 32 modern healthcare facilities, including 4 hospitals and 28 outpatient clinics in Moscow and Moscow region, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, and Vladimir.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.